Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300075375Phase 4Recruiting
Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by Ningbo Zhenhai District Traditional Chinese Medicine Hospital. Primary endpoint: Time between the end of general anesthesia and the first eye opening. Started Sep 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300075375.